Streetbeat News

Price Targets

PRTG

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Portage Biotech (NASDAQ:PRTG) but reduced the price target from $9 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 8:01 pm

BRZE

Braze (NASDAQ:BRZE) has received analyst ratings over the last quarter with 7 bullish, 10 somewhat bullish, and 3 indifferent ratings. No somewhat bearish or bearish ratings were reported. The average 12-month price target for Braze is $55.35, with a high of $65.00 and a low of $48.00. This target has increased by 19.7% over the past month. Analysts rate stocks based on research and provide guidance on performance metrics.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 8:00 pm

MPW

Over the past 3 months, 5 Wall Street analysts have rated Medical Properties Trust (NYSE:MPW) with 1 somewhat bullish, 1 indifferent, and 3 somewhat bearish ratings. The average price target is now $5.5, down 38.89% from the previous $9.00, suggesting an upside from the current price of $4.885.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 8:00 pm

VEEV

Veeva Systems (NYSE:VEEV) has received mixed analyst ratings in the last quarter, with 3 bullish, 6 somewhat bullish, 5 indifferent, and 1 somewhat bearish. Over the past 3 months, 15 analysts have set a 12-month price target for VEEV, with an average target of $216.47, a high of $265.00, and a low of $160.00. The current average price target represents a 1.03% increase from the previous target of $214.27. Analysts typically review stocks quarterly or after major company updates, basing their ratings on financial predictions and company performance metrics.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 8:00 pm

ES

Eversource Energy (NYSE:ES) has received 12 indifferent analyst ratings in the last quarter with no bullish or bearish ratings. The average price target is $64.08, representing an implied upside from the current price of $60.12. This average price target has decreased by 11.37% from the previous target of $72.30. Analysts typically review stocks once a quarter and provide forecasts on earnings, revenue, and growth, although their predictions are not infallible.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 8:00 pm

COO

Cooper Companies (NASDAQ:COO) has received 4 analyst ratings in the past quarter, with 1 bullish and 3 indifferent. The average 12-month price target is $377.0, a 2.71% decrease from the previous target of $387.50. Analysts provide ratings based on financial analysis and company performance, and these ratings can influence investor decisions.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 8:00 pm

CL

Colgate-Palmolive (NYSE:CL) has received a mix of bullish and indifferent analyst ratings over the last quarter, with no bearish ratings. The average price target among 10 analysts is $81.9, which is higher than the current price of $78.0, suggesting an upside. However, this target is a 3.51% decrease from the previous target of $84.88. Analysts' ratings are based on company data, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 8:00 pm

VEEV

JP Morgan analyst Anne Samuel has maintained a Neutral rating on Veeva Systems (NYSE:VEEV) and reduced the price target from $188 to $183.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 7:58 pm

COO

JP Morgan analyst Robbie Marcus has maintained a Neutral rating on Cooper Companies (NASDAQ:COO) and reduced the price target from $385 to $375.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 7:57 pm

MDLZ

JP Morgan analyst Ken Goldman has maintained an Overweight rating on Mondelez International (NASDAQ:MDLZ) but has reduced the price target from $84 to $82.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 7:55 pm